Abiopharma

New Form 424B5 - ETHZilla Corp Filed: 2025-08-22 AccNo: 0001213900-25-080000 Size: 902 KB

New Form F-3 - ONCOLYTICS BIOTECH INC Filed: 2025-08-22 AccNo: 0001104659-25-081954 Size: 544 KB

Hughes Steven George 🟡 adjusted position in 2.2K shares (1 derivative) of Avidity Biosciences, Inc. (RNA) at $46.40 Transaction Date: Aug 22, 2025 | Filing ID: 000166

New Form 8-K - IOVANCE BIOTHERAPEUTICS, INC. Filed: 2025-08-22 AccNo: 0001104659-25-081953 Size: 497 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Director Matheis Dennis 🟢 acquired 100.0K shares of Lucid Diagnostics Inc. (LUCD) at $1.02 Transaction Date: Aug 20, 2025 | Filing ID: 014853

New Form DEF 14A - Cosmos Health Inc. Filed: 2025-08-22 AccNo: 0001477932-25-006195 Size: 805 KB

New Form 424B5 - IOVANCE BIOTHERAPEUTICS, INC. Filed: 2025-08-22 AccNo: 0001104659-25-081949 Size: 613 KB

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

New Form 8-K - Salarius Pharmaceuticals, Inc. Filed: 2025-08-22 AccNo: 0001628280-25-041043 Size: 8 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Director BREEN EDWARD D 🟡 adjusted position in 14.4K shares of DuPont de Nemours, Inc. (DD) Transaction Date: Aug 20, 2025 | Filing ID: 014847

New Form 8-K - ModivCare Inc Filed: 2025-08-22 AccNo: 0001437749-25-027610 Size: 190 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Aptose Biosciences Inc. Filed: 2025-08-22 AccNo: 0001171843-25-005555 Size: 219 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 144 - SUPERNUS PHARMACEUTICALS, INC. Filed: 2025-08-22 AccNo: 0001950047-25-006280 Size: 4 KB

Indivior Notification